Latest Sarcoma Stories
Morcellator lawsuits filed on behalf of women who allegedly experienced the spread of uterine sarcoma and other malignancies have been mounting in U.S.
GOTHENBURG, Sweden, CAMBRIDGE, England and CLINTON, New Jersey, February 5, 2015 /PRNewswire/ -- Isofol (http://www.isofolmedical.com), a clinical stage pharmaceutical
MADRID, February 3, 2015 /PRNewswire/ -- PharmaMar announces that the U.S.
RARITAN, N.J., Feb. 3, 2015 /PRNewswire/ -- Janssen Research & Development, LLC (Janssen) announced today that the U.S.
Power Morcellator Lawsuits Are Being Filed On Behalf Of Women Who Underwent A Hysterectomy Or Myomectomy To Remove Fibroids And Was Later Diagnosed With Cancer That Allegedly Was Spread By The
Aldoxorubicin Demonstrates 2-Fold Increase in Likelihood of Surviving More than 2 Years versus Doxorubicin and 27% Reduction in the Risk of Death LOS ANGELES, Jan.
PINEHURST, N.C., Jan.
Aldoxorubicin Showed 66% Complete or Partial Responses and No Tumor Progression in KS Patients with Excellent Tolerability LOS ANGELES, Jan.
ReportsnReports.com adds “Rhabdomyosarcoma - Pipeline Review, H2 2014” to its store.
The publication of this latest power morcellator study follows warnings from U.S.
Kaposi's sarcoma-associated herpesvirus (KSHV) one of seven currently known human cancer virus, is also the eighth human herpesvirus. Kaposi's sarcoma, caused by the virus, is common in AIDS patients, primary effusion lymphoma, and some types of multicentric Castelman's disease. Moritz Kaposi discovered the blood vessel tumor, in 1872, which would eventually be names Kaposi's sarcoma. It was originally though that KS was of Jewish and Mediterranean origins until it was found to be common...